We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$103B
AUM Growth
+$3.66B
Cap. Flow
+$2.96B
Cap. Flow %
2.88%
Top 10 Hldgs %
12.16%
Holding
4,809
New
469
Increased
2,314
Reduced
1,430
Closed
297

Sector Composition

Rank Sector Weight
1 Financials 13.25%
2 Healthcare 11.22%
3 Technology 10.98%
4 Industrials 7.83%
5 Energy 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCO
3501
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
$550K ﹤0.01%
15,600
-19,000
-55% -$740K
PJP icon
3502
Invesco Pharmaceuticals ETF
PJP
$442M
$549K ﹤0.01%
7,007
-1,641
-19% -$128K
ALTO icon
3503
Alto Ingredients
ALTO
$369M
$548K ﹤0.01%
53,092
-34,115
-39% -$393K
XHB icon
3504
PUT
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$546K ﹤0.01%
14,900
-18,800
-56% -$679K
STOR
3505
DELISTED
STORE Capital Corporation
STOR
$546K ﹤0.01%
27,148
-8,672
-24% -$188K
FPX icon
3506
First Trust US Equity Opportunities ETF
FPX
$1.47B
$544K ﹤0.01%
9,974
+2,528
+34% +$138K
RESP
3507
DELISTED
WisdomTree U.S. ESG Fund
RESP
$544K ﹤0.01%
22,158
-516
-2% -$12.9K
FBC
3508
DELISTED
Flagstar Bancorp, Inc. New
FBC
$544K ﹤0.01%
29,443
+14,619
+99% +$254K
CASS icon
3509
Cass Information Systems
CASS
$714M
$543K ﹤0.01%
12,738
+6,149
+93% +$245K
VIRX
3510
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$543K ﹤0.01%
860
+756
+727% +$402K
CRAI icon
3511
CRA International
CRAI
$1.16B
$542K ﹤0.01%
19,454
-2,876
-13% -$84.2K
ATCO
3512
DELISTED
Atlas Corp.
ATCO
$542K ﹤0.01%
28,731
-9,342
-25% -$184K
AKBA icon
3513
Akebia Therapeutics
AKBA
$354M
$541K ﹤0.01%
52,552
+24,801
+89% +$212K
LKFN icon
3514
Lakeland Financial Corp
LKFN
$1.56B
$541K ﹤0.01%
18,687
+3,208
+21% +$87K
SPB icon
3515
Spectrum Brands
SPB
$2.04B
$540K ﹤0.01%
+5,300
New +$498K
DALN
3516
DELISTED
DallasNews
DALN
$539K ﹤0.01%
+24,076
New +$633K
MITT
3517
TPG Mortgage Investment Trust
MITT
$222M
$538K ﹤0.01%
10,376
+1,073
+12% +$60.4K
SYNH
3518
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$538K ﹤0.01%
13,403
-1,075
-7% -$37.1K
VTOL icon
3519
Bristow Group
VTOL
$1.34B
$537K ﹤0.01%
13,125
+357
+3% +$15.3K
STNR
3520
DELISTED
STEINER LEISURE LTD
STNR
$537K ﹤0.01%
10,001
+883
+10% +$44.5K
SLVO icon
3521
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$11.3M
$536K ﹤0.01%
2,458
-6,399
-72% -$1.45M
FORM icon
3522
FormFactor
FORM
$8.28B
$534K ﹤0.01%
58,070
-17,041
-23% -$155K
HNGR
3523
DELISTED
Hanger Inc.
HNGR
$534K ﹤0.01%
22,786
-31,176
-58% -$728K
QTWO icon
3524
Q2 Holdings
QTWO
$3.8B
$532K ﹤0.01%
+18,843
New +$441K
LGCY
3525
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$531K ﹤0.01%
61,807
-22,299
-27% -$246K

Similar funds

Credit Suisse's Q2 2015 Portfolio in Review

As of Q2 2015, Credit Suisse held 4,809 positions worth $103B, up 3.7% from $99B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Credit Suisse's Q2 2015 filing shows 469 new, 2,314 increased, 1,430 reduced and 297 closed positions. Its largest new stake was UBS Group: 120,749,322 shares worth $2.56B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.67B.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

  • Credit Suisse's largest Q2 2015 buy was UBS Group: 120,749,322 shares worth $2.56B.
  • Credit Suisse added most to iShares MSCI Emerging Markets ETF in Q2 2015, an estimated $343M increase.
  • Credit Suisse's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.67B.
  • Credit Suisse fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $101M.
  • Credit Suisse's ten largest holdings make up 12% of its $103B portfolio in Q2 2015.
  • Credit Suisse opened 469 new positions and closed 297 in Q2 2015.
  • Credit Suisse's portfolio value rose 3.7% quarter-over-quarter to $103B.

Based on Credit Suisse's 13F filing for Q2 2015, filed 13 Aug 2015.